Apr 15, 2026
In this episode (watch on YouTube), we take a closer look at Buntanetap, an investigational therapy that is gaining attention for its potential to target the underlying biology of Parkinson’s disease—not just the symptoms.
Unlike traditional treatments that focus on dopamine replacement, Buntanetap works upstream by...
Apr 1, 2026
Fibroblast Growth Factor-1 (FGF-1) is being discussed as a potential regenerative therapy for Parkinson’s disease. Some claim it may protect or even restore dopamine-producing neurons. But what does the science actually say?
In this episode, we break down:
• What FGF-1 is and how it works
• Why growth factors are...